Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)

Ashraf Z Badros, MD, Elizabeth Hyjek, MD PhD, Ning Ma, Alexander M. Lesokhin, MD, Aaron P. Rapoport, MD, Mehmet H. Kocoglu, MD, Emily Lederer, RN, Sunita Philip, MBBS, Patricia Lesho, Ashlee Johnson, Cameron Dell, Olga Goloubeva, PhD, Zeba Singh, MD

Blood (2016) 128 (22): 490.

https://doi.org/10.1182/blood.V128.22.490.490

Published: 2016

Journal Articles

Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm By Using 10-Colour Flow Cytometry and Achievement of Remission By Hypercvad Therapy

Uday Deotare, MD DM, Elizabeth Hyjek, MD PhD, Anna Porwit, MDPhD, Rumina Musani, MDFCAP, FRCPC, David Barth, MD FRCPC, Emina Torlakovic, MD, Anne Tierens, MD PhD, Aaron D Schimmer, MDPhD, Andre C Schuh, MD FRCPC, Mark D. Minden, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Matthew D. Seftel, MRCP, FRCPC, MPH, Naheed Alam, MBBS,MD, Karen W.L. Yee, MDFRCPC

Blood (2014) 124 (21): 2365.

https://doi.org/10.1182/blood.V124.21.2365.2365

Published: 2014

Journal Articles

PLZF Staining Identifies Peripheral T-Cell Lymphomas Derived From Non-Conventional T-Cells With Limited α-Chain Diversity

Stephanie McGregor, MD, PhD, Anant Shah, Gordana Raca, Kamran Mirza, MD PHD, John Anastasi, MD, James W. Vardiman, MD, Elizabeth Hyjek, MD, PhD, Sandeep Gurbuxani, MBBS, PhD

Blood (2013) 122 (21): 4300.

https://doi.org/10.1182/blood.V122.21.4300.4300

Published: 2013

Journal Articles

Targeting Angiogenesis in Mantle Cell Lymphoma: Clinical Efficacy and Correlative Studies of a Phase II Trial of RT-PEPC (Rituximab, Thalidomide and Metronomic Oral Chemotherapy with Prednisone, Etoposide, Procarbazine and Cyclophosphamide) in Relapsed/Refractory Disease.

Jia Ruan, MD, PhD, Morton Coleman, MD, Richard R. Furman, MD, Patricia Glynn, Maureen Joyce, Jamie Ketas, Ken Cheung, PhD, Sarah Church, Tsiporah Shore, MD, Eric Feldman, MD, Sarah Rutherford, Elizabeth Hyjek, MD, PhD, Amy Chadburn, MD, Shahin Rafii, MD, John P. Leonard, MD

Blood (2006) 108 (11): 2751.

https://doi.org/10.1182/blood.V108.11.2751.2751

Published: 2006

Journal Articles

Correlation of Clinical and Molecular Response to Imatinib in Polycythemia Vera (PV) Patients with Bone Marrow Morphologic and Immunophenotypic Changes.

Elizabeth Hyjek, MD, PhD, Amy Chadburn, MD, Nicholas C.P. Cross, PhD, Amy V. Jones, BSc, Su-Chieh P. Sun, MS, Susan Mathew, PhD, April Chiu, MD, April Young, MS, D.M. Knowles, MD, Richard T. Silver, MD

Blood (2006) 108 (11): 4914.

https://doi.org/10.1182/blood.V108.11.4914.4914

Published: 2006

Journal Articles

Neither Germinal Center (GC) vs Non-Germinal Center (Non-GC) Phenotype nor FOXP1 Expression Correlate with Outcome in AIDS-Associated Diffuse Large B-Cell Lymphoma (DLBCL): Study of Patients from AIDS Malignancies Consortium Trials 010 and 034.

Amy Chadburn, MD, Xia Chen, MD PhD, April Chiu, MD, Elizabeth Hyjek, MD PhD, Wayne Tam, MD PhD, Lawrence Kaplan, MD, David T. Scadden, MD, Daniel M. Knowles, MD, Ethel Cesarman, MD PhD

Blood (2006) 108 (11): 2023.

https://doi.org/10.1182/blood.V108.11.2023.2023

Published: 2006

Journal Articles

Stromal Incorporation of VEGFR-1 + , CD68 + and α-SMA + Hemangiogenic Cells Correlates with Histologic Subtype in Non-Hodgkin’s Lymphoma.

Jia Ruan, MD, PhD, Elizabeth Hyjek, MD, PhD, Andrea T. Hooper, Loic Vincent, PhD, Pouneh Kermani, PhD, Paul J. Christos, M.P.H., MS, Sherry Ikalowych, MD, Morton Coleman, MD, Barbara Hempstead, MD, PhD, John P. Leonard, MD, Amy Chadburn, MD, Shahin Rafii, MD

Blood (2005) 106 (11): 1930.

https://doi.org/10.1182/blood.V106.11.1930.1930

Published: 2005

NARROW

Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)

Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm By Using 10-Colour Flow Cytometry and Achievement of Remission By Hypercvad Therapy

PLZF Staining Identifies Peripheral T-Cell Lymphomas Derived From Non-Conventional T-Cells With Limited α-Chain Diversity

Targeting Angiogenesis in Mantle Cell Lymphoma: Clinical Efficacy and Correlative Studies of a Phase II Trial of RT-PEPC (Rituximab, Thalidomide and Metronomic Oral Chemotherapy with Prednisone, Etoposide, Procarbazine and Cyclophosphamide) in Relapsed/Refractory Disease.

Correlation of Clinical and Molecular Response to Imatinib in Polycythemia Vera (PV) Patients with Bone Marrow Morphologic and Immunophenotypic Changes.

Neither Germinal Center (GC) vs Non-Germinal Center (Non-GC) Phenotype nor FOXP1 Expression Correlate with Outcome in AIDS-Associated Diffuse Large B-Cell Lymphoma (DLBCL): Study of Patients from AIDS Malignancies Consortium Trials 010 and 034.

Stromal Incorporation of VEGFR-1 + , CD68 + and α-SMA + Hemangiogenic Cells Correlates with Histologic Subtype in Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)

Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm By Using 10-Colour Flow Cytometry and Achievement of Remission By Hypercvad Therapy

PLZF Staining Identifies Peripheral T-Cell Lymphomas Derived From Non-Conventional T-Cells With Limited α-Chain Diversity

Targeting Angiogenesis in Mantle Cell Lymphoma: Clinical Efficacy and Correlative Studies of a Phase II Trial of RT-PEPC (Rituximab, Thalidomide and Metronomic Oral Chemotherapy with Prednisone, Etoposide, Procarbazine and Cyclophosphamide) in Relapsed/Refractory Disease.

Correlation of Clinical and Molecular Response to Imatinib in Polycythemia Vera (PV) Patients with Bone Marrow Morphologic and Immunophenotypic Changes.

Neither Germinal Center (GC) vs Non-Germinal Center (Non-GC) Phenotype nor FOXP1 Expression Correlate with Outcome in AIDS-Associated Diffuse Large B-Cell Lymphoma (DLBCL): Study of Patients from AIDS Malignancies Consortium Trials 010 and 034.

Stromal Incorporation of VEGFR-1 + , CD68 + and α-SMA + Hemangiogenic Cells Correlates with Histologic Subtype in Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only